ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.83
0.00%
US Tech 100
21,066.40
-0.04%
S&P 500
6,061.48
0.39%
US Dollar vs CAD
1.43495
0.23%
Bitcoin
98,979.61
2.44%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Skinbiotherapeutics Plc (SBTX) Share Price

Skinbiotherapeutics Plc

Skinbiotherapeutics Plc (SBTX)

LSE
18.875
0.00
( 0.00% )
Updated: 01:48:38
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
18.875
Bid
18.50
Ask
19.25
Volume
51,870
18.875 Day's Range 18.875
7.25 52 Week Range 19.375
Market Cap
42.674M
Previous Close
18.875
Open
18.875
Last Trade
5000
@
18.5375
(O)
Last Trade Time
04:44:40
Financial Volume
-
VWAP
-
Average Volume (3m)
860,746
Shares Outstanding
226,086,285
Dividend Yield
-
PE Ratio
-15.10
Earnings Per Share (EPS)
-0.01
Revenue
132k
Net Profit
-2.84M

About Skinbiotherapeutics Plc

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.skinbiotherapeutics.com
Headquarters
Newcastle Upon Tyne, Gbr
Founded
-
Skinbiotherapeutics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker SBTX. The last closing price for Skinbiotherapeutics was 18.88p. Over the last year, Skinbiotherapeutics shares have traded in a share price range of 7.25p to 19.375p.

Skinbiotherapeutics currently has 226,086,285 shares outstanding. The market capitalization of Skinbiotherapeutics is £42.67 million. Skinbiotherapeutics has a price to earnings ratio (PE ratio) of -15.10.

Ask ADVFN Intelligence (AI)

SBTX Latest News

More News

SkinBioTherapeutics PLC Result of AGM

SkinBioTherapeutics PLC 27 December 2024     SkinBioTherapeutics plc ("SkinBioTherapeutics" or "the Group")   Result of Annual General Meeting   27 December 2024 - SkinBioTherapeutics plc...

December 27 2024
RNS Regulatory News

SkinBioTherapeutics PLC Holding(s) in Company

SkinBioTherapeutics PLC 12 December 2024   TR-1: Standard form for notification of major holdings     NOTIFICATION OF MAJOR HOLDINGS(to be sent to the relevant issuer and to the FCA in...

December 12 2024
RNS Regulatory News

SkinBioTherapeutics PLC Posting of Annual Report and Notice of AGM

SkinBioTherapeutics PLC 04 December 2024   SkinBioTherapeutics plc   Posting of Annual Report and AGM Notice   4 December 2024 - SkinBioTherapeutics plc, (AIM: SBTX, or the "Company"), a life...

December 04 2024
RNS Regulatory News

SkinBioTherapeutics PLC Final Results

SkinBioTherapeutics PLC 04 December 2024     SkinBioTherapeutics plc ("SkinBioTherapeutics" or "the Group")                                                                                      ...

December 04 2024
RNS Regulatory News

SkinBioTherapeutics PLC Notice of Results

SkinBioTherapeutics PLC 04 December 2024     SkinBioTherapeutics plc ("SkinBioTherapeutics" or "the Group")   Timing of FY results announcement 4 December 2024 - SkinBioTherapeutics plc (AIM:...

December 04 2024
RNS Regulatory News

SkinBioTherapeutics PLC Notice of Results

SkinBioTherapeutics PLC 29 November 2024     SkinBioTherapeutics plc ("SkinBioTherapeutics" or "the Group")   Notice of Full Year results and Investor Meet Company presentation 29 November...

November 29 2024
RNS Regulatory News

SkinBioTherapeutics PLC Finalisation of commercial agreement with Croda

SkinBioTherapeutics PLC 19 November 2024     SkinBioTherapeutics plc ("SkinBioTherapeutics" or "the Company")   Finalisation of commercial agreement with Croda Beauty Care for SkinBiotix ·   ...

November 19 2024
RNS Regulatory News

SkinBioTherapeutics PLC Holding(s) in Company

SkinBioTherapeutics PLC 25 October 2024     TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in...

October 25 2024
RNS Regulatory News

IN BRIEF: SkinBioTherapeutics boosts financial 2025 turnover forecast

cs PLC - Newcastle, England-based skin health-focused life sciences company - Says the integration of its GBP1.3 milli ...

October 23 2024
Alliance News

SkinBioTherapeutics PLC Integration update and share price movement

SkinBioTherapeutics PLC 23 October 2024     SkinBioTherapeutics plc ("SkinBioTherapeutics" or "the Group")   Integration of new acquisition started No reason for share price movement ·   ...

October 23 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.8754.861111111111819.1517.2565360118.29658769DE
42.7517.054263565916.12519.1514.7548220117.2818767DE
125.2538.532110091713.62519.37513.2586074616.981233DE
265.62542.452830188713.2519.37510.25108668714.4500542DE
527.37564.130434782611.519.3757.25100545412.75733337DE
156-21.125-52.812540547.2559882817.10408567DE
2606.12548.039215686312.75875.7567977826.78226868DE

SBTX - Frequently Asked Questions (FAQ)

What is the current Skinbiotherapeutics share price?
The current share price of Skinbiotherapeutics is 18.875p
How many Skinbiotherapeutics shares are in issue?
Skinbiotherapeutics has 226,086,285 shares in issue
What is the market cap of Skinbiotherapeutics?
The market capitalisation of Skinbiotherapeutics is GBP 42.67M
What is the 1 year trading range for Skinbiotherapeutics share price?
Skinbiotherapeutics has traded in the range of 7.25p to 19.375p during the past year
What is the PE ratio of Skinbiotherapeutics?
The price to earnings ratio of Skinbiotherapeutics is -15.1
What is the cash to sales ratio of Skinbiotherapeutics?
The cash to sales ratio of Skinbiotherapeutics is 314.5
What is the reporting currency for Skinbiotherapeutics?
Skinbiotherapeutics reports financial results in GBP
What is the latest annual turnover for Skinbiotherapeutics?
The latest annual turnover of Skinbiotherapeutics is GBP 132k
What is the latest annual profit for Skinbiotherapeutics?
The latest annual profit of Skinbiotherapeutics is GBP -2.84M
What is the registered address of Skinbiotherapeutics?
The registered address for Skinbiotherapeutics is THE CORE BATH LANE, NEWCASTLE HELIX, MACCLESFIELD, NEWCASTLE UPON TYNE, NE4 5TF
What is the Skinbiotherapeutics website address?
The website address for Skinbiotherapeutics is www.skinbiotherapeutics.com
Which industry sector does Skinbiotherapeutics operate in?
Skinbiotherapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BODBotswana Diamonds Plc
0.195p
(39.29%)
38.13M
NOGNostrum Oil & Gas Plc
3.50p
(25.00%)
4.22k
BBGIBbgi Global Infrastructure S.a.
142.40p
(16.91%)
23.94M
FXPOFerrexpo Plc
85.40p
(16.03%)
3.42M
ONCOncimmune Holdings Plc
9.95p
(15.03%)
4.74k
RAIRa International Group Plc
0.95p
(-85.38%)
22.07M
ARKArkle Resources Plc
0.20p
(-20.00%)
507.13k
W7LWarpaint London Plc
437.50p
(-17.76%)
1.65M
TPXTpximpact Holdings Plc
26.50p
(-17.19%)
100.14k
TUNTungsten West Plc
2.75p
(-15.38%)
113.28k
NTVONativo Resources Plc
0.0017p
(0.00%)
578.02M
ORCPOracle Power Plc
0.017p
(8.97%)
567.9M
SRCSigmaroc Plc
74.70p
(6.11%)
180.48M
CPAICapai Plc
0.0445p
(0.00%)
179.63M
SYMESupply@me Capital Plc
0.0029p
(5.45%)
175.52M

Discussion

View Full Feed
StayHumble StayHumble 1 minute ago
💹✅ https://theqcup.com/patents
HCMC
glenn1919 glenn1919 1 minute ago
SLXN......RZLV......GPRO.......MRSN......................https://stockcharts.com/h-sc/ui?s=RZLV&p=D&yr=0&mn=3&dy=0&id=p11960084343
GPRO MRSN RZLV
JustJack JustJack 5 minutes ago
So you are ok when people say this is going to $10.00?

It was .0099 less than 6 months ago and now .0027

Devices suck and are not good enough to be needed.

Almost 14 billion shares diluted and many bag holders. 

Good luck to you buddy.
AITX
glenn1919 glenn1919 5 minutes ago
BBAI......SBET.....RANI.....REBN....LAES.....https://stockcharts.com/h-sc/ui?s=BBAI&p=D&yr=0&mn=3&dy=0&id=p11960084343
BBAI LAES REBN
penguin007 penguin007 6 minutes ago
I understand the borrowing/financing that must be done for greater good. Then why show net profits? It seems that there might be a contradiction of information reported and perhaps what's going on behind the scenes? I still hold a position, so I do have vested interest with AXXA. I'm just not seeing
AXXA
SkeBallLarry SkeBallLarry 6 minutes ago
Andrea Mitchell to depart as MSNBC news anchor >

after 17 years on Friday >
https://www.msn.com/en-us/politics/international-relations/andrea-mitchell-to-depart-as-msnbc-news-anchor-after-17-years-on-friday/ar-AA1ytGAC?ocid=BingNewsSerp
Huggy Bear Huggy Bear 7 minutes ago
.000001
KEGS
SkeBallLarry SkeBallLarry 7 minutes ago
Andrea Mitchell to depart as MSNBC news anchor >

after 17 years on Friday >
https://www.msn.com/en-us/politics/international-relations/andrea-mitchell-to-depart-as-msnbc-news-anchor-after-17-years-on-friday/ar-AA1ytGAC?ocid=BingNewsSerp
SkeBallLarry SkeBallLarry 8 minutes ago
Andrea Mitchell to depart as MSNBC news anchor >

after 17 years on Friday >
https://www.msn.com/en-us/politics/international-relations/andrea-mitchell-to-depart-as-msnbc-news-anchor-after-17-years-on-friday/ar-AA1ytGAC?ocid=BingNewsSerp
dheminger dheminger 8 minutes ago
The chart is starting to curl back. Technically we are starting to look pretty good. Few more days at .0018 and we are going to have a golden cross on the 50MA
ATWT
SkeBallLarry SkeBallLarry 9 minutes ago
Andrea Mitchell to depart as MSNBC news anchor >

after 17 years on Friday >
https://www.msn.com/en-us/politics/international-relations/andrea-mitchell-to-depart-as-msnbc-news-anchor-after-17-years-on-friday/ar-AA1ytGAC?ocid=BingNewsSerp
capgain capgain 12 minutes ago
I hear ya, it never stops.

Try and have a good one.
barnyarddog barnyarddog 14 minutes ago
Disney First Quarter Earnings Beat Expectations, Boosted By Streaming Service

“Overall, this quarter proved to be a strong start to the fiscal year, and we remain confident in our strategy for continued growth,” said Disney CEO Bob Iger in a statement.

February 05 2025
FUBO
hopester hopester 17 minutes ago
RIGHT!
FCEL
hopester hopester 17 minutes ago
All the Institutions so lauded in having huge interests in FCEL are down huge.. Turns out Blackrock is the HOGWASH of the group.
FCEL
Here Today Here Today 18 minutes ago
Couldn't sleep last night and was doing so online light reading and came across the following post from Large_Barber1116 from a couple months back which looks very interesting since it goes into a lot of detail:

VDRM
StayHumble StayHumble 19 minutes ago
$AMC Silver investments Golden💹ShortFilmXplosion Coming✅💹 huzzah!!

"...............Enjoy the Show..........."
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
AMC
Moonboy1 Moonboy1 23 minutes ago
Just watching this train wreck from the sidelines. I won't be buying this for any reason any more. They have proven to me they are nothing but a bunch of thieves. But any time the FDA is involved it's pretty much just theft. Otherwise they would be legalizing weed and herbs instead of these these
TNXP
StayHumble StayHumble 24 minutes ago
SEC💹Catches🎅🏿+👽ArtificiallyDeflating Prices✅2Buy Shares Cheaper

6, 12, 2023. —
SEC charged investment adviser Sabby Management LLC & managing partner,Hal D. Mintz,w/ fraud in connection w/ a long running scheme involving misrepresenta
DBMM GTII HCMC
golfbag golfbag 24 minutes ago
Welcome to iHub. You've made some interesting points in your posts, I think most of us old-timers would be interested in learning about his history with NioCorp or the industry.
NB
baltimorebullet baltimorebullet 24 minutes ago
If I thought the drug was helping my brain I wouldn't even tell my doc about most side effects lest she discontinue the meds.
AVXL
Nelson2 Nelson2 28 minutes ago
Niiiice! Obviously they feel stock is underpriced

“The company has indicated that it’s interested in using the proceeds from the Cylance deal, along with the positive cash flow that it’s now generating, to facilitate repurchases of BB stock.

GLTA
BB
Fully Diluted Fully Diluted 28 minutes ago
Good morning Nats,

The calculation of the share price is much simpler: if 7.2 billion shares (warrants redeemed) are worth 250 billion dollars, then one share is worth 34.72 USD. Such an approach also avoids confusion regarding a JPS conversion.

I think HUD should have
FNMA

Your Recent History

LSE
SBTX
Skinbiotherapeutics
BOV
BRKM3
BRASKEM ON
BIT
I07005
Intesa Sanpaolo
BIT
I09184
Intesa Sanpaolo
BIT
F34726
Vontobel Financial Produ...
BIT
XZEZ
Xtrackers Msci Emu Esg U...
BOV
DIVD11
It Now IDIV Renda Divide...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads